Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-25

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping \& Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo) or persistent following pregnancy complicated by hypertension.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate

NCT05867459

CKD PREGNANT WOMEN

UNKNOWN

Renin and Prorenin in Pregnancy

NCT00005207

Cardiovascular Diseases Heart Diseases Hypertension +2 more

COMPLETED

Telocytes in Umbilical Cord of Patients With and Without Pre-eclampsia

NCT05305339

Telocytes in Umbilical Cord of Pregnancies Complicated by Chronic Hypertension, Gestational Hypertension and Preeclampsia

UNKNOWN

Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler

NCT02541110

Preeclampsia IUGR

UNKNOWN

CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

NCT04729361

IUGR Prenatal Disorder Genetic Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

denovo postpartum hypertension

females with new onset hypertension after delivary

No interventions assigned to this group

persitant postpartum hypertension

females with preexisting hypertension or preeclampsia that persist after delivery

No interventions assigned to this group

control

females with normal postpartum blood pressure

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals

Exclusion Criteria

* All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No